Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD
Clinical trial NCT01210560 · COMPLETED
Trial details
- NCT number
- NCT01210560
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2011-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.